Cell3TM Direct Fetal RhD Group Genotyping Kit

Reduce Cost & Time in Fetal RhD Diagnosis Using Cell Free Fetal DNA

With no cfDNA extraction required, Cell3TM Direct, reduces cost and saves time in fetal Rhesus D diagnosis with sample to result in under three hours.

Save Time and Reduce Cost

Save Time and Reduce Cost

With no cfDNA extraction required, Cell3TM Direct, reduces cost and saves time in fetal Rhesus D diagnosis with sample to result in under three hours.

Less Material Required

Less Material Required

Uses less than <0.25ml of plasma sample, leaving plenty of sample for further tests.

Fully Validated

Fully Validated

Validated kit and flexible format to fit with laboratory processing. Multiple targeted approach to provide intra assay concordance.

Robust and Accurate Reporting

Robust and Accurate Reporting

96 well formatting within a break-apart plate allows for testing of up to 13 samples per kit. Validated protocol ensures accurate reporting of findings.

 

The First Direct From Plasma NIPD Test

The first direct from plasma non-invasive prenatal diagnosis kit for Fetal RhD Genotyping provides a quicker, more cost effective and validated assay. The Cell3™ Direct Fetal RhD Group Genotyping kit targets sequences specific for exons 5, 7 and 10 of the RhD gene and can distinguish between RhD positive, RhD negative and RhD PSI genotypes in cfDNA.

The First Direct From Plasma NIPD Test

 

 

 

Meet New NICE Guidelines on Fetal Rhesus D Status

 

Meet New NICE Guidelines on Fetal Rhesus D Status

NICE now recommends tests to identify fetal Rhesus D status to the UK NHS. They state “Maternity services should start offering pregnant women who are rhesus negative a test to identify the status of their fetus, under final guidance issued by the National Institute for Health and Care Excellence.

 

 

 

 

Superior technical performance

Quantitative PCR data on cfDNA samples extracted with column-based extraction kits revealed that the Cell3TMXtract kit performed on par with the Company Q kit and outperformed the Company A kit. However, the use of carrier RNA in the Company Q kit resulted in a higher DNA concentration measurement (~50 fold) and the appearance of a high molecular weight peak in the fragment analysis electropherogram.

Superior technical performance Superior technical performance

 

 

 

Product Support

If you have a query relating to any of our products please fill in the support request form here and one of our team will get back to you as soon as possible.

Contact

info@AramisGen.com

T: +98(21)88985291-3 

F: +98(21)89775181

Postal code: 1416673744

Italia St.

Teran

Iran

 

20+1-1=?